Artificial Intelligence can help predict the chances of survival in women with ovarian cancer, new research suggests.
Dundee life sciences company Exscientia has set its sights on becoming the “dominant player” in the use of artificial intelligence to discover new drugs after a $26 million cash injection.
Dundee-based drug discovery company Exscientia yesterday announced it is opening a new office in Oxford.
The benefits of artificial intelligence (AI) are evident, but is it also a threat to the very existence of humanity? Michael Alexander sought the opinions of experts.
A Dundee computational drug discovery firm has secured its second major industry tie-up in a matter of weeks after agreeing a potential £33 million deal with pharma giant GSK.